Arrowhead Pharmaceuticals's market cap is currently $2.58B. The company's EPS TTM is $-5.149; its P/E ratio is ―; Arrowhead Pharmaceuticals is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 3.55M	$ 240.74M	$ 243.23M	$ 138.29M	$ 87.99M
Gross Profit	$ 3.55M	$ 240.74M	$ 232.81M	$ 138.29M	$ 87.99M
Operating Income	$ -601.08M	$ -205.00M	$ -178.51M	$ -149.04M	$ -93.16M
EBITDA	$ -561.51M	$ -175.67M	$ -162.29M	$ -132.58M	$ -87.22M
Net Income	$ -599.49M	$ -205.28M	$ -176.49M	$ -140.85M	$ -84.55M
Balance Sheet
Cash & Short-Term Investments	$ 680.96M	$ 403.63M	$ 376.40M	$ 367.79M	$ 315.49M
Total Assets	$ 1.14B	$ 765.55M	$ 691.94M	$ 710.15M	$ 522.50M
Total Debt	$ 510.55M	$ 115.17M	$ 81.58M	$ 25.55M	$ 21.14M
Net Debt	$ 407.87M	$ 4.28M	$ -26.43M	$ -158.89M	$ -122.44M
Total Liabilities	$ 948.74M	$ 478.39M	$ 585.98M	$ 301.33M	$ 60.72M
Stockholders' Equity	$ 185.44M	$ 271.34M	$ 105.96M	$ 408.82M	$ 461.78M
Cash Flow
Free Cash Flow	$ -604.32M	$ -330.63M	$ -188.91M	$ 147.66M	$ -107.34M
Operating Cash Flow	$ -462.85M	$ -153.89M	$ -136.13M	$ 171.22M	$ -95.39M
Investing Cash Flow	$ -420.07M	$ -96.16M	$ -5.42M	$ -141.68M	$ -240.78M
Financing Cash Flow	$ 870.52M	$ 253.05M	$ 65.19M	$ 11.30M	$ 257.95M

Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

Income Statement >

Arrowhead Pharmaceuticals Debt to Assets

Balance Sheet >

Arrowhead Pharmaceuticals Cash Flow

Cash Flow >

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing